Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology  |  Family Medicine  |  Sleep

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Insomnia Clinical Trials

A listing of Insomnia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (36) clinical trials

Outpatient study designed to test a new investigational medication in adults 50 years and older with insomnia. Compensation is $1450. To qualify, you must be 50 years and older. Length of study: 4-6 weeks Overnight visits: 5 Total number of outpatient visits: 6 For more information,

Phase N/A

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia. To qualify, you must be: 18 years and older Length of study: 6 weeks Overnight visits: 10 Total number of outpatient visits: 1 For more information,

Phase N/A

If you are having trouble staying asleep almost every night, you may qualify for a research study of an investigational sleep medication. If you are 18 years of age or older And not able to sleep through the night 4 or more times a week Please call Commonwealth Clinical Research ...

Phase N/A

Idiopathic hypersomnia is sleeping too much without an obvious cause. It is different from narcolepsy, because it does not involve suddenly falling asleep or losing muscle control due to strong emotions. NeuroTrials Research is conducting a new research study on the safety & efficacy of a new investigational drug for ...

Phase N/A

The purpose of this study is to see if the study drug, suvorexant, is safe and effective in treating symptoms of insomnia in people with Parkinson's Disease. It is anticipated that a total of 20 subjects, 30 to 80 years of age, with Parkinson's Disease and symptoms of insomnia will ...

Phase

The study aims to understand the effectiveness of a six-week course of light exposure on cognitive functioning, mood, activity, and sleep in people that have suffered a mild traumatic brain injury (mTBI) or "concussion." The entire study lasts 13 weeks with only 4 visits to Banner UMC and includes six ...

Phase N/A

Eisai is studying a drug called lemborexant or E2006, being developed to potentially treat people with insomnia disorder. The main goal of this study is to compare the effectiveness of two strengths of lemborexant with another drug called zolpidem tartrate extended release tablets (also known as Ambien® Controlled Release tablets) ...

Phase

Northern California Research is currently enrolling participants for an insomnia study. The primary focus of this study is to determine if the study medication, lemborexant, compared to a placebo has a beneficial effect for people who suffer from insomnia. There will be two different dosages of lemborexant 5mg and 10mg ...

Phase

Are you suffering from INSOMNIA? Are you having trouble falling asleep or staying asleep. If yes, you may be eligible for a clinical research study.

Phase

Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder

Participants will be randomized to receive double-blind suvorexant or placebo for one week, after which all participants will receive open treatment with suvorexant for three months.

Phase